By Dr Vendula Belackova

Journal articles

Rodgers C; Siefried KJ; Ritter A; Belackova V; Treloar C; Jauncey M; Ezard N; Roberts D; Steele M; van den Brink W; Strang J; Oviedo-Joekes E; Lintzeris N; Dunlop AJ; Bell J, 2024, 'Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-082553

Wiessing L; Banka-Cullen P; Barbaglia MG; Belackova V; Belbaisi SAS; Blanken P; Carrieri P; Comiskey C; Dacosta-Sánchez D; Dom G; Fabricius V; Faria H; Ignjatova L; Inić N; Jacobsen B; Javakhishvili JD; Kamendy Z; Kapitány-Fövény M; Kiss A; Kyprianou E; Marchand K; Millar T; Mravcik V; Mustafa NJY; Nordt C; Partanen M; Pedersen MU; Putkonen H; Razmadze M; Roux P; Schulte B; Seabra P; Sordo L; Strada L; Subata E; Thoma E; Torrens M; Walley AY; Yiasemi I, 2024, 'Correction: Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report (International Journal of Mental Health and Addiction, (2023), 10.1007/s11469-023-01213-9)', International Journal of Mental Health and Addiction, http://dx.doi.org/10.1007/s11469-024-01242-y

Belackova V; Rychert M; Wilkins C; Pardal M, 2023, 'Cannabis Social Clubs in Contemporary Legalization Reforms: Talking Consumption Sites and Social Justice', Clinical Therapeutics, 45, pp. 551 - 559, http://dx.doi.org/10.1016/j.clinthera.2023.03.017

Wiessing L; Banka-Cullen P; Barbaglia MG; Belackova V; Belbaisi SAS; Blanken P; Carrieri P; Comiskey C; Dacosta-Sánchez D; Dom G; Fabricius V; Faria H; Ignjatova L; Inić N; Jacobsen B; Javakhishvili JD; Kamendy Z; Kapitány-Fövény M; Kiss A; Kyprianou E; Marchand K; Millar T; Mravcik V; Mustafa NJY; Nordt C; Partanen M; Pedersen MU; Putkonen H; Razmadze M; Roux P; Schulte B; Seabra P; Sordo L; Strada L; Subata E; Thoma E; Torrens M; Walley AY; Yiasemi I, 2023, 'Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report', International Journal of Mental Health and Addiction, http://dx.doi.org/10.1007/s11469-023-01213-9

Guarita B; Belackova V; van der Gouwe D; Blankers M; Pazitny M; Griffiths P, 2021, 'Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103210

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Drapalova E; Belackova V; Cadet-Tairou A, 2020, 'How to ask about the use of new psychoactive substances to increase the validity of results in self-report prevalence surveys (vol 39, pg 278, 2020)', DRUG AND ALCOHOL REVIEW, 39, pp. 774 - 774, http://dx.doi.org/10.1111/dar.13141

Belackova V; Salmon AM; Jauncey M; Day CA, 2020, 'Safer injecting facilities—is the research there? A comment on Caulkins et al. (2019)', Addiction, 115, pp. 784 - 785, http://dx.doi.org/10.1111/add.14885

Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M, 2020, 'Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type', Drug and Alcohol Dependence, 209, http://dx.doi.org/10.1016/j.drugalcdep.2020.107909

Belackova V, 2020, '“The Good, the Bad, and the Ugly Weed”: How Consumers in Four Different Policy Settings Define the Quality of Illicit Cannabis', Contemporary Drug Problems, 47, pp. 43 - 62, http://dx.doi.org/10.1177/0091450919897658

Drapalova E; Belackova V; Cadet-Taïrou A, 2020, 'How to ask about the use of new psychoactive substances to increase the validity of results in self-report prevalence surveys', Drug and Alcohol Review, 39, pp. 278 - 286, http://dx.doi.org/10.1111/dar.13036

Belackova V; Salmon AM; Jauncey M; Bell J, 2019, 'Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia's responses to opioid misuse?', International Journal of Drug Policy, 71, pp. 164 - 168, http://dx.doi.org/10.1016/j.drugpo.2019.01.026

Belackova V; Roubalova (Stefunkova) M; van de Ven K, 2019, 'Overview of “home” cultivation policies and the case for community-based cannabis supply', International Journal of Drug Policy, 71, pp. 36 - 46, http://dx.doi.org/10.1016/j.drugpo.2019.05.021

Drapalova E; Belackova V; Calado D; Van Dongen A; Paneva I; Pavarin R; Polidori E; Grund JP, 2019, 'Early Identification of Locally Emerging Trends in Psychoactive Substance Use–Experience and Best Practice in Four European Localities', Substance Use and Misuse, 54, pp. 1633 - 1645, http://dx.doi.org/10.1080/10826084.2019.1600146

Belackova V; Silins E; Salmon AM; Jauncey M; Day CA, 2019, 'Beyond safer injecting—health and social needs and acceptance of support among clients of a supervised injecting facility', International Journal of Environmental Research and Public Health, 16, http://dx.doi.org/10.3390/ijerph16112032

Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M, 2019, 'Drug consumption rooms: A systematic review of evaluation methodologies', Drug and Alcohol Review, 38, pp. 406 - 422, http://dx.doi.org/10.1111/dar.12919

Belackova V; Brandnerova M; Vechet D, 2018, 'How Close to the “Honeypot?”: A Comparative Analysis of Cannabis Markets Under Two Different Policies Toward Personal Cultivation', International Criminal Justice Review, 28, pp. 206 - 225, http://dx.doi.org/10.1177/1057567717744857

Bell J; Belackova V; Lintzeris N, 2018, 'Supervised Injectable Opioid Treatment for the Management of Opioid Dependence', Drugs, 78, pp. 1339 - 1352, http://dx.doi.org/10.1007/s40265-018-0962-y

Coomber R; Moyle L; Belackova V; Decorte T; Hakkarainen P; Hathaway A; Laidler KJ; Lenton S; Murphy S; Scott J; Stefunkova M; van de Ven K; Vlaemynck M; Werse B, 2018, 'The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview', International Journal of Drug Policy, 58, pp. 93 - 103, http://dx.doi.org/10.1016/j.drugpo.2018.05.010

Belackova V; Wilkins C, 2018, 'Consumer agency in cannabis supply – Exploring auto-regulatory documents of the cannabis social clubs in Spain', International Journal of Drug Policy, 54, pp. 26 - 34, http://dx.doi.org/10.1016/j.drugpo.2017.12.018

Belackova V; Pazitny M; Drapalova E; Martinez M; van der Gouwe D; Begley E; Kidawa M; Tomkova A; Kmetonynova D, 2018, 'Assessing the impact of laws controlling the online availability of 25I-NBOMe, AH-7921, MDPV and MXE–outcomes of a semi-automated e-shop monitoring', Drugs: Education, Prevention and Policy, 25, pp. 109 - 117, http://dx.doi.org/10.1080/09687637.2016.1275526

Belackova V; Stefunkova M, 2018, 'Interpreting the Czech drug decriminalization: The glass is half full – Response to Cerveny, J., Chomynova, P., Mravcik, V., & van Ours, J.C. (2017). Cannabis decriminalization and the age of onset of cannabis use', International Journal of Drug Policy, 52, pp. 102 - 105, http://dx.doi.org/10.1016/j.drugpo.2017.10.010

Belackova V; Shanahan M; Ritter A, 2018, 'Mapping regulatory models for medicinal cannabis: A matrix of options', Australian Health Review, 42, pp. 403 - 411, http://dx.doi.org/10.1071/AH16257

Belackova V; Salmon AM; Schatz E; Jauncey M, 2018, 'Drug consumption rooms (DCRs) as a setting to address hepatitis C - findings from an international online survey.', Hepatol Med Policy, 3, pp. 9, http://dx.doi.org/10.1186/s41124-018-0035-6

Belackova V; Vacek J; Janikova B; Mravcik V; Zabransky T; Ivanovova L; Csemy L, 2017, '“Just another drug” for marginalized users: The risks of using synthetic cathinones among NSP clients in the Czech Republic', Journal of Substance Use, 22, pp. 567 - 573, http://dx.doi.org/10.1080/14659891.2016.1271034

Belackova V; Janikova B; Vacek J; Fidesova H; Miovsky M, 2017, '“It can’t happen to me”: Alcohol drinkers on the 2012 outbreak of methanol poisonings and the subsequent prohibition in the Czech Republic', NAD Nordic Studies on Alcohol and Drugs, 34, pp. 385 - 399, http://dx.doi.org/10.1177/1455072517733597

Brunt TM; Atkinson AM; Nefau T; Martinez M; Lahaie E; Malzcewski A; Pazitny M; Belackova V; Brandt SD, 2017, 'Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price', International Journal of Drug Policy, 44, pp. 105 - 114, http://dx.doi.org/10.1016/j.drugpo.2017.03.006

Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; Comiskey C; Rossi C; Griffiths P; Molinaro S; Franchini M; Siciliano V; Benedetti E; Perduca M; Ylli A; Anta GB; Bravo Portela MJ; Indave I; Rácz J; Zábranskỳ T; Štefunková M; Dávila PF; Salekesin M; Vorobjov S; Dan M; Fierbinteanu C; Popescu D; Verdes L; Abagiu AO; Hatzakis A; Moudatsou M; Antypas T; Cadet-Tairou A; Collins AM; Liddell D; Belackova V, 2017, 'Monitoring quality and coverage of harm reduction services for people who use drugs: A consensus study', Harm Reduction Journal, 14, pp. 19, http://dx.doi.org/10.1186/s12954-017-0141-6

Belackova V; Ritter A; Shanahan M; Hughes CE, 2017, 'Assessing the concordance between illicit drug laws on the books and drug law enforcement: Comparison of three states on the continuum from “decriminalised” to “punitive”', International Journal of Drug Policy, 41, pp. 148 - 157, http://dx.doi.org/10.1016/j.drugpo.2016.12.013

M. Salmon A; Belackova V; Schwanz RS; Jauncey M; Hiley S; Demirkol A, 2017, 'Homelessness among clients of Sydney’s supervised injecting facility', Drugs and Alcohol Today, 17, pp. 258 - 268, http://dx.doi.org/10.1108/DAT-06-2017-0026

Belackova V; Tomkova A; Zabransky T, 2016, 'Qualitative research in Spanish cannabis social clubs: “The moment you enter the door, you are minimising the risks”', International Journal of Drug Policy, 34, pp. 49 - 57, http://dx.doi.org/10.1016/j.drugpo.2016.04.009

Belackova V; Maalsté N; Zabransky T; Grund JP, 2016, 'Corrigendum to "'Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic' [Int. J. Drug Policy 26 (2015) 296-310] DOI: 10.1016/j.drugpo.2014.12.002', International Journal of Drug Policy, 29, pp. 102, http://dx.doi.org/10.1016/j.drugpo.2016.01.018

Drápalová E; Grund JPC; Běláčková V, 2016, 'Evaluating potential hazards of new trends in psychoactive substance use, literature review of “risk assessment” procedures', Adiktologie, 16, pp. 145 - 154

Drápalová E; Běláčková V, 2016, 'Monitoring of discussion forums on new psychoactive substances in the Czech Republic, content and trends', Adiktologie, 16, pp. 131 - 142

Mravčík V; Grohmannová K; Štefunková M; Běláčková V; Zábranský T, 2016, 'Narcotic and psychotropic substances are …, a proposal for a legal definition of illicit drugs in the Czech Republic', Adiktologie, 16, pp. 157 - 164

Grohmannová K; Kmetonyová D; Štefunková M; Běláčková V; Zábranský T; Mravčík V, 2016, 'Online sales of new synthetic drugs in the Czech Republic in 2015', Adiktologie, 16, pp. 121 - 128

Otte R; Běláčková V; Schoenmakers A; Grund JPC, 2016, 'The local PASS toolkit: A local approach towards the reduction of psychoactive substance use', Adiktologie, 16, pp. 167 - 171

Běláčková V; Janíková B; Tomková A; Vacek J; Zábranský T; Mravčík V; Csémy L, 2016, 'The use of new synthetic drugs among problem drug users, prevalence, patterns of use, and related risks as a challenge for harm reduction programmes in the Czech Republic', Adiktologie, 16, pp. 107 - 119

Miovsky M; Miller PM; Grund JPC; Belackova V; Gabrhelik R; Libra J, 2015, 'Academic education in addictology (addiction science) in the Czech Republic: Analysis of the (pre-1989) historical origins', NAD Nordic Studies on Alcohol and Drugs, 32, pp. 527 - 538, http://dx.doi.org/10.1515/nsad-2015-0050

Mravčík V; Běláčková V; Grohmannová K; Zábranský T, 2015, 'New psychoactive substances and their prevalence in the Czech Republic', Casopis Lekaru Ceskych, 154, pp. 216 - 221

Belackova V; Maalsté N; Zabransky T; Grund JP, 2015, '"Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic', International Journal of Drug Policy, 26, pp. 296 - 310, http://dx.doi.org/10.1016/j.drugpo.2014.12.002

Miovsky M; Zima T; Popov P; Fidesova H; Vacek J; Belackova V; Janikova B; Trapencieris M; Snikere S; Pulmanis T; Razvodovsky Y; Toteva S; Zhenkov V; Razvodovsky Y, 2013, 'O5 * FREE ORAL COMMUNICATIONS 5: ALCOHOL-RELATED SOCIETY AND POLICY CHANGES IN EUROPEAN COUNTRIES', Alcohol and Alcoholism, 48, pp. i38 - i39, http://dx.doi.org/10.1093/alcalc/agt097

Back to profile page